The new rule would prevent Florida minors from receiving puberty blockers, hormone therapy or surgeries as treatment for gender dysphoria.
The board is slated to meet again Nov. 4 to discuss the proposed rule. Once drafted, the board would launch a 28-day approval process that includes time for public comments.
Florida’s efforts to restrict gender-affirming care date back to April, when the health department released guidance recommending against nonurgent care. In August, Florida’s Medicaid regulator also finalized rules banning healthcare providers from billing Medicaid for gender-affirming medical treatment.
Read the full article here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
